Sign in
4

Changes in Ownership

Eledon Pharmaceuticals, Inc. Filed Acc 0000950170-24-130272

Options or other derivatives

  • Chief Executive Officer acquired 1,015,743 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Gros David-Alexandre C · Chief Executive Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-11-21 Grant or award : show line 1 in the form Stock Option (right to buy) +1,015,743 1,015,743 D
Loading xslF345X05/ownership.xml…